Skip to Content
MilliporeSigma

Inducible de novo expression of neoantigens in tumor cells and mice.

Nature biotechnology (2020-07-29)
Martina Damo, Brittany Fitzgerald, Yisi Lu, Mursal Nader, Ivana William, Julie F Cheung, Kelli A Connolly, Gena G Foster, Elliot Akama-Garren, Da-Yae Lee, Greg P Chang, Vasilena Gocheva, Leah M Schmidt, Alice Boileve, Josephine H Wilson, Can Cui, Isabel Monroy, Prashanth Gokare, Peter Cabeceiras, Tyler Jacks, Nikhil S Joshi
ABSTRACT

Inducible expression of neoantigens in mice would enable the study of endogenous antigen-specific naïve T cell responses in disease and infection, but has been difficult to generate because leaky antigen expression in the thymus results in central T cell tolerance. Here we develop inversion-induced joined neoantigen (NINJA), using RNA splicing, DNA recombination and three levels of regulation to prevent leakiness and allow tight control over neoantigen expression. We apply NINJA to create tumor cell lines with inducible neoantigen expression, which could be used to study antitumor immunity. We also show that the genetic regulation in NINJA mice bypasses central and peripheral tolerance mechanisms and allows for robust endogenous CD8 and CD4 T cell responses on neoantigen induction in peripheral tissues. NINJA will enable studies of how T cells respond to defined neoantigens in the context of peripheral tolerance, transplantation, autoimmune diseases and cancer.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Doxycycline hyclate
Supelco
4-Hydroxytamoxifen, analytical standard, (E) and (Z) isomers (50:50)
Sigma-Aldrich
N-Acetyl-D-lactosamine, ≥98% (TLC)
Sigma-Aldrich
4-Hydroxytamoxifen Ready Made Solution, 5 mg/mL in ethanol: isopropanol (95:5)